Table 3.

Inhibition zone in susceptibility testing of Acinetobacter baumannii and Pseudomonas aeruginosa (mm)

Isolate	Ceftazidime 30 μg	Ceftriaxone 30 μg	Ampicillin/sulbactam 10/10 μg	Meropenem 10 μg	Gentamicin 10 μg	Cotrimoxazole 25 μg	Piperacillin/tazobactam 100/10 μg	Ciprofloxacin 5 μg	Amikacin 30 μg
1	11	7	16	9	NA	8	12	10	13
2	10	8	17	9	NA	8	11	10	12
3	12	8	17	11	NA	7	12	11	12
4	12	6	10	12	NA	9	18	9	9
5	11	5	9	9	NA	8	13	11	13
6	10	6	16	11	NA	9	12	13	14
7	18	6	17	6	NA	10	19	10	15
8	13	7	17	6	NA	5	21	12	11
9	10	5	10	6	NA	9	14	10	17
10	11	6	9	10	NA	6	15	8	18
11	10	7	7	9	NA	5	12	10	14
12	10	8	9	8	NA	5	11	11	12
13	19	6	11	7	NA	8	14	16	13
14	9	5	8	8	NA	7	13	11	11
15	12	5	16	16	NA	7	12	12	10
16	13	6	18	17	NA	5	11	10	18
17	11	9	7	9	NA	6	14	10	9
18	14	12	8	15	11	NA	14	17	18
19	13	10	9	13	10	NA	13	13	19
20	13	10	8	20	8	NA	14	14	12
21	19	15	7	13	8	NA	21	21	21
22	19	21	6	19	10	NA	21	22	19
23	18	21	15	22	15	NA	22	18	20
24	12	10	7	14	9	NA	23	15	15
25	11	11	9	14	8	NA	14	21	18
26	19	13	10	19	7	NA	13	14	15
27	13	22	9	20	17	NA	13	22	14
28	11	21	8	21	17	NA	21	14	16
29	11	11	8	13	9	NA	22	22	18

NA, not applicable.